HALB Halberd Corp (PK)

0.00 (0.0%)
Last Updated: 15:41:08
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 1,014,922
Bid Price 0.0084
Ask Price 0.009
News -
Day High 0.009


52 Week Range


Day Low 0.0084
Company Name Stock Ticker Symbol Market Type
Halberd Corp (PK) HALB OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.009 15:41:08
Open Price Low Price High Price Close Price Prev Close
0.00861 0.0084 0.009 0.009
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
26 1,014,922 $ 0.008467 $ 8,593 - 0.0032 - 0.0196
Last Trade Time Type Quantity Stock Price Currency
15:41:08 100 $ 0.009 USD

Halberd Corp (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.18M 565.87M 280.54M 8k -1.63M 0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Halberd (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No HALB Message Board. Create One! See More Posts on HALB Message Board See More Message Board Posts

Historical HALB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01060.01060.0080.0090508969,232-0.0016-15.09%
1 Month0.00940.01220.00720.00917951,187,167-0.0004-4.26%
3 Months0.00830.01220.00720.0091373801,6230.00078.43%
6 Months0.01420.01670.0070.01012071,030,001-0.0052-36.62%
1 Year0.00960.01960.00320.01036091,173,755-0.0006-6.25%
3 Years0.00580.1090.00320.0355765,675,8510.003255.17%
5 Years0.00130.1090.00040.02907825,158,6160.0077592.31%

Halberd (PK) Description

Halberd Corp is a research-based company seeking to develop treatments for a range of diseases. Their extracorporeal method treats blood-borne, neurologic and infectious diseases. Halberd's patents remove bodily fluids in a continuous fashion, like dialysis, or in a batch process. To treat the specific disease, the treatment is applied to the bodily fluid. Disease eradication via exposure to radio frequency, laser irradiation, or chemical bonding. The cleansed bodily fluids are then returned to the patient without deadly side effects found with injected or ingested medications. Halberds technology base is 4 issued patents and 22 pending patents: Current projects with planned submissions of abstracts to ARPA-H include: * Extracorporeal eradication of inflammatory cytokines from cerebrospinal fluid associated with PTSD and Suicidal Ideation * Therapeutic lozenges to alleviate pain and anxiety as well as chemical and alcohol addiction * Eradication of antibiotic-resistant bacteria and deadly Candida Auris fungi supplied by CDC * Development of a nasal spray is in pre-clinical testing designed to eliminate neurodegenerative cascade associated of head trauma * Extracorporeal eradication of antigens associated with cancer * Extracorporeal eradication of the 10 inflammatory cytokines & the excitatory neurotransmitter associated with Alzheimer's Disease, Parkinson's Disease & Epilepsy * Development of antibodies against Coronavirus & extracorporeal eradication of Covid antigens.
Your Recent History
Halberd (P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now